Domma Secures €950,000 for Menopause Research and Solutions

Secways leading the round reflects a growing recognition of the importance of addressing menopause-related challenges through biotechnological solutions and digital support. This investment signifies a commitment to expanding access to innovative solutions for managing menopause symptoms and addressing associated stigma. By leveraging biotechnology and digital platforms, Secways aims to reach a broader audience and provide more comprehensive support for individuals navigating menopause. 

Absolutely, Domma's initiative represents a proactive and innovative approach to addressing the often-overlooked health needs of women experiencing menopause. By providing scientifically backed natural alternatives and personalized support plans, Domma aims to improve the quality of life for women during this transitional phase. This focus on women's health and well-being is crucial in ensuring that individuals receive the support and resources they need to navigate menopause with confidence and comfort. Furthermore, by building a community and fostering open discussions around menopause, Domma is helping to reduce stigma and promote awareness about this important stage in women's lives. Overall, initiatives like Domma have the potential to have a significant positive impact on women's health and empower individuals to embrace this natural phase of life with vitality and resilience.

Domma's successful funding round, led by Secways and supported by Antai Ventures, strategic business angels, and ENISA, highlights a growing recognition of the importance of addressing menopause-related challenges. With €950,000 in equity and debt, Domma aims to bolster scientific research and develop innovative biotechnological solutions to enhance women's health during menopause. Founders Cristina Martínez and Mireia Roca are focused on leveraging this capital to advance digital support for individuals transitioning through menopause and to broaden their consumer reach. This investment underscores a commitment to advancing women's health and well-being by leveraging technology and biotechnology to address an often-overlooked aspect of women's health.

Cristina Martínez's emphasis on combating menopause stigma underscores Domma's commitment to providing personalized support and solutions tailored to individual needs. Secways and Antai Ventures' praise for Domma's leadership and mission reflects their recognition of the startup's potential to make a meaningful impact on the quality of life for women navigating through menopause. This endorsement highlights the importance of addressing menopause-related challenges and the value of innovative solutions in promoting women's health and well-being.

Domma's product lineup offers a comprehensive range of solutions to address hormonal and emotional imbalances during menopause. These include scientifically backed natural alternatives such as superfood and adaptogen blends for hormonal regulation, nutritional supplements for libido and sexual well-being, intimate serums, sleep improvement supplements, and relaxing herbal teas. With a focus on personalized menopause treatment and support plans, including digital solutions to boost female libido, Domma has garnered over a thousand subscribers and achieved a remarkable 350% growth in 2023, its second year of operation. This growth has led to the development of a community of over 100,000 women dedicated to climacteric and mature female health. Headquartered in Barcelona, Domma operates with a ten-person team and is poised for further expansion and impact in the women's health sector.